Document is current
Any future updates will be listed below
-
Authors
Flory, Stephan
Guglielmini, Sabino
Scholkmann, Felix
Marcar, Valentine L.
Wolf, Martin
- License Information
-
More Information
Article History
Received: 12 September 2022
Accepted: 20 July 2023
First Online: 25 July 2023
Competing interests
: The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. F. Scholkmann consulted for NIRx Medizintechnik GmbH (Berlin, Germany) on an unrelated subject matter. M. Wolf is president of the board and cofounder of OxyPrem AG.
